Glucose Health Operating Income 2014-2019 | GLUC

Glucose Health operating income from 2014 to 2019. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

Glucose Health Operating Income 2014-2019 | GLUC

Glucose Health operating income from 2014 to 2019. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$206.3B
Stryker (SYK)$148B
Boston Scientific (BSX)$133.7B
EssilorLuxottica (ESLOY)$111.2B
Medtronic (MDT)$110.6B
Haleon (HLN)$44B
Lonza Group Ag (LZAGY)$42.2B
GE HealthCare Technologies (GEHC)$37.9B
ResMed (RMD)$36.6B
Terumo (TRUMY)$30.3B
Koninklijke Philips (PHG)$25.5B
Zimmer Biomet Holdings (ZBH)$22.3B
Insulet (PODD)$18.7B
Baxter (BAX)$17B
Smith & Nephew SNATS (SNN)$11.2B
BellRing Brands (BRBR)$9.9B
Bio-Rad Laboratories (BIO)$9.5B
Demant (WILYY)$8.3B
Lantheus Holdings (LNTH)$6.3B
TG Therapeutics (TGTX)$5.4B
Haemonetics (HAE)$4.4B
Prestige Consumer Healthcare (PBH)$4.2B
Perrigo (PRGO)$3.9B
ICU Medical (ICUI)$3.9B
Envista Holdings (NVST)$3.8B
Agios Pharmaceuticals (AGIO)$3.3B
Neogen (NEOG)$3.1B
Shandong Weigao Medical Polymer (SHWGF)$3B
GN Store Nord (GNNDY)$2.9B
QuidelOrtho (QDEL)$2.8B